A signaling-optimized TIGIT chimeric switch receptor promotes metabolic fitness and antitumor efficacy of TCR/CAR T cells
Edite Antunes Ferreira, Kevin Jan Legscha, Ulrike Regina Schmits, Alexandra Reinbrecht, Matthias Theobald, Hakim Echchannaoui
This paper introduces a fine-tuned chimeric switch receptor (CSR) that enhances TCR/CAR T cell metabolic fitness and antitumor efficacy by optimizing signaling from the TIGIT domain.
bioRxiv · Oct 8, 2026 · PreprintImmunology